Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| Increases Bacteroides ovatus - : 5,6-dihydro-9,10-dimethoxybenzo[g]-1,3-benzodioxolo[5,6-a]quinolizinium {Berberine} |
👶
Berberine protects against diet-induced obesity through regulating metabolic endotoxemia and gut hormone levels. Molecular medicine reports (Mol Med Rep ) Vol: 15 Issue 5 Pages: 2765-2787 Pub: 2017 May Epub: 2017 Mar 14 Authors Xu JH , Liu XZ , Pan W , Zou DJ , Html Article Publication |
| Increases Bacteroides ovatus - : 5,6-dihydro-9,10-dimethoxybenzo[g]-1,3-benzodioxolo[5,6-a]quinolizinium {Berberine} |
👶
Significant pharmacokinetic differences of berberine are attributable to variations in gut microbiota between Africans and Chinese. Scientific reports (Sci Rep ) Vol: 6 Issue Pages: 27671 Pub: 2016 Jun 10 Epub: 2016 Jun 10 Authors Alolga RN , Fan Y , Chen Z , Liu LW , Zhao YJ , Li J , Chen Y , Lai MD , Li P , Qi LW , Html Article Publication |
| Increases Bacteroides ovatus - : 5,6-dihydro-9,10-dimethoxybenzo[g]-1,3-benzodioxolo[5,6-a]quinolizinium {Berberine} |
👶
Modulation of gut microbiota by berberine and metformin during the treatment of high-fat diet-induced obesity in rats. Scientific reports (Sci Rep ) Vol: 5 Issue Pages: 14405 Pub: 2015 Sep 23 Epub: 2015 Sep 23 Authors Zhang X , Zhao Y , Xu J , Xue Z , Zhang M , Pang X , Zhang X , Zhao L , Html Article Publication |
| Increases Bacteroides ovatus - : 5,6-dihydro-9,10-dimethoxybenzo[g]-1,3-benzodioxolo[5,6-a]quinolizinium {Berberine} |
👶
Structural changes of gut microbiota during berberine-mediated prevention of obesity and insulin resistance in high-fat diet-fed rats. PloS one (PLoS One ) Vol: 7 Issue 8 Pages: e42529 Pub: 2012 Epub: 2012 Aug 3 Authors Zhang X , Zhao Y , Zhang M , Pang X , Xu J , Kang C , Li M , Zhang C , Zhang Z , Zhang Y , Li X , Ning G , Zhao L , Html Article Publication |
| Increases Bacteroides ovatus - : 5,6-dihydro-9,10-dimethoxybenzo[g]-1,3-benzodioxolo[5,6-a]quinolizinium {Berberine} |
👶
Berberrubine, a Main Metabolite of Berberine, Alleviates Non-Alcoholic Fatty Liver Disease via Modulating Glucose and Lipid Metabolism and Restoring Gut Microbiota. Frontiers in pharmacology (Front Pharmacol ) Vol: 13 Issue Pages: 913378 Pub: 2022 Epub: 2022 Jul 8 Authors Yang S , Cao S , Li C , Zhang J , Liu C , Qiu F , Kang N , Html Article Publication |
